To call my medical career a series of random pivots is an understatement. I have multiple sclerosis (MS) to thank for this wandering journey, one with an uncertain destination, but a surprisingly meaningful landing place. Anesthesiology was my first love. I adored tinkering with the anesthesia machine, working with…
Read more
Specific disease-modifying therapies (DMTs) significantly slow the rate of brain volume loss in adults with multiple sclerosis (MS), a benefit that is directly linked to reduced long-term disability, according to a new review. A network meta-analysis of more than 26,000 patients confirms that therapies most effective at preserving…
A signaling molecule called erythropoietin (EPO) plays a key role in allowing the immune system to distinguish the body’s own cells from foreign threats, a study found. The findings could lead to new treatments for diseases like multiple sclerosis (MS), in which the immune system inadvertently starts to attack…
Due to my uneasiness with heights, I complained a lot about parachuting throughout my career in the U.S. Army. There’s a small chance, however, that I haven’t been entirely fair. Sure, I was afraid every time, made some less-than-stellar landings, and sustained a few injuries, but those were really…
Gadoquatrane, a contrast agent Bayer is developing for MRI scans, showed similar safety and pharmacokinetic (PK) profiles — meaning how a drug moves into, through, and out of the body — in both children and adults. That’s according to data from the Phase 3 QUANTI Pediatric study (NCT05915026),…
Get regular updates to your inbox.
